Login / Signup

Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.

Namyoung PaikDong Hyun SinnJi H LeeIn S OhJung Hee KimWonseok KangGeum-Youn GwakYong-Han PaikMoon S ChoiJoon H LeeKwang C KohSeung W Paik
Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)
The combined use of two non-invasive serum biomarkers (APRI and FIB-4) could stratify HCC risk for chronic HBV-infected patients with LLV.
Keyphrases
  • hepatitis b virus
  • drug induced
  • breast cancer risk